On April 18, 2023, Madrigal Pharmaceuticals, a clinical-stage biopharmaceutical company, announced that its drug candidate resmetirom has received the Breakthrough…
On April 21, 2023, XORTX Therapeutics Inc., a clinical-stage biopharmaceutical company, announced that it has received the Orphan Drug Designation…
On April 17, 2023, the combination of botensilimab (AGEN1181) and balstilimab (AGEN2034) has been granted fast-track designation by the FDA…
On April 21, 2023, Medtronic plc (NYSE: MDT), a global leader in medical technology, announced FDA approval of its MiniMed…
On April 20, 2023, LuxCreo, a leading 3D printing specialist in clear dental appliances, announced an FDA Class II 510(k)…